Smartleaf Asset Management
CTKB icon

Smartleaf Asset Management’s Cytek Biosciences CTKB Stock Holding History

Smartleaf Asset Management’s Portfolio CTKB Stock Details CTKB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$887 Buy
+154
New +$730 ﹤0.01% 3227
2026
Q1 		– Sell
-127
Closed -$640 – 3541
2025
Q4 		$640 Buy
+127
New +$590 ﹤0.01% 3234
2025
Q2 		– Sell
-361
Closed -$1.44K – 2778
2025
Q1 		$1.44K Sell
361
-552
-60% -$2.86K ﹤0.01% 2543
2024
Q4 		$5.98K Sell
913
-237
-21% -$1.41K ﹤0.01% 2183
2024
Q3 		$6.2K Buy
1,150
+624
+119% +$3.54K ﹤0.01% 2022
2024
Q2 		$2.89K Buy
+526
New +$3.16K ﹤0.01% 2070

Other funds holding CTKB

Boston Partners
Boston Partners Boston, Massachusetts $111B AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return
Royce & Associates
Royce & Associates New York $11B AUM 39.4% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $57.2B AUM 42.49% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Smartleaf Asset Management's CTKB Position: Q3 2026 in Review

Smartleaf Asset Management opened a new position in Cytek Biosciences (CTKB) in Q3 2026: 154 shares worth $887. The stake represents ﹤0.01% of the portfolio and ranks #3227 among its holdings. This is a return to the name: Smartleaf Asset Management previously reported a position in CTKB as recently as Q4 2025.

Smartleaf Asset Management first reported a position in CTKB in Q2 2024 and has held it in 6 quarters since. The position peaked at $6.2K in Q3 2024. 68 funds tracked by Wall St. Rank hold CTKB as of Q3 2026.

  • Smartleaf Asset Management held 154 shares of Cytek Biosciences worth $887 as of Q3 2026.
  • Cytek Biosciences was a new Smartleaf Asset Management position in Q3 2026.
  • Cytek Biosciences made up ﹤0.01% of Smartleaf Asset Management's portfolio in Q3 2026, its #3227 holding.
  • Smartleaf Asset Management first reported a position in Cytek Biosciences in Q2 2024 and has held it in 6 quarters since.
  • Smartleaf Asset Management's Cytek Biosciences position peaked at $6.2K in Q3 2024.
  • 68 funds tracked by Wall St. Rank held Cytek Biosciences as of Q3 2026.

Based on Smartleaf Asset Management's 13F filing for Q3 2026, filed 10 Nov 2026.